Johnson & Johnson, Legend’s CAR-T Carvykti enters myeloma ring with FDA nod aliu Mon, 02/28/2022 – 12:59

COVID-19 tracker: Adamis’ COVID-19 trial with Tempol is a go; Brutal omicron surge sweeps through Hong Kong admin […]

Trevi revs up extended-release opioid cough program, exiting phase 2 early and racing into next stage ssorensen Mon, […]

COPD Foundation links arms with Ena on antiviral nasal spray ahead of phase 2 trials in COVID-19, flu […]

Editor’s Corner: Fierce Pharma gets a fierce makeover esagonowsky Fri, 02/25/2022 – 09:38

A clinical trial has shown that the immunotherapy drug pembrolizumab increased survival rates for head and neck cancer […]

Recently published research determined that the Epic Systems Corporation Sepsis Model—a widely implemented electronic health record (EHR) based […]

Unmet need among over 7000 rare diseases is being addressed in a comprehensive action plan

Quviviq can be used on a long-term basis, addressing a key limitation of existing therapies

Lexicon pulls FDA submission for sotagliflozin to fix ‘technical issue,’ plans prompt refiling esagonowsky Mon, 02/28/2022 – 10:34